Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
4(21%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
21%
Ph phase_1
5
26%
Ph phase_2
1
5%
Ph phase_4
6
32%
Ph phase_3
3
16%

Phase Distribution

5

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
5(26.3%)
Phase 2Efficacy & side effects
1(5.3%)
Phase 3Large-scale testing
3(15.8%)
Phase 4Post-market surveillance
6(31.6%)
N/ANon-phased studies
4(21.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

19

all time

Status Distribution
Active(7)
Completed(9)
Other(3)

Detailed Status

Completed9
Recruiting3
unknown3
Not yet recruiting2
Enrolling by invitation1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (26.3%)
Phase 21 (5.3%)
Phase 33 (15.8%)
Phase 46 (31.6%)
N/A4 (21.1%)

Trials by Status

recruiting316%
unknown316%
enrolling_by_invitation15%
active_not_recruiting15%
completed947%
not_yet_recruiting211%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT06977841Not Applicable

Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial

Completed
NCT07277712Phase 1

A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers

Not Yet Recruiting
NCT07242456Phase 2

Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication

Recruiting
NCT06743243Phase 4

Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia

Enrolling By Invitation
NCT06991348Phase 4

Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole

Recruiting
NCT06523764Phase 4

Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment

Active Not Recruiting
NCT06894992Not Applicable

Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment

Recruiting
NCT06318104Phase 4

Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole

Not Yet Recruiting
NCT05577468Phase 3

Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori

Completed
NCT05701540Phase 4

A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn

Unknown
NCT05870683Not Applicable

Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection (SHARE2301)

Unknown
NCT05915871Phase 1

Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin

Completed
NCT05871398Phase 3

The Efficacy of Potassium-competitive Acid Blocker in Patients With Laryngopharyngeal Reflux Disease

Completed
NCT04309916Phase 4

Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance

Completed
NCT04674774Not Applicable

Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection

Unknown
NCT04128917Phase 3

Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT

Completed
NCT04639804Phase 1

Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers

Completed
NCT04066257Phase 1

Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers

Completed
NCT03378284Phase 1

A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19